Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 3
2009 1
2010 2
2011 2
2012 1
2013 2
2014 2
2015 1
2016 2
2018 2
2019 1
2020 1
2021 2
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer.
Cortes J, Rugo HS, Cescon DW, Im SA, Yusof MM, Gallardo C, Lipatov O, Barrios CH, Perez-Garcia J, Iwata H, Masuda N, Torregroza Otero M, Gokmen E, Loi S, Guo Z, Zhou X, Karantza V, Pan W, Schmid P; KEYNOTE-355 Investigators. Cortes J, et al. N Engl J Med. 2022 Jul 21;387(3):217-226. doi: 10.1056/NEJMoa2202809. N Engl J Med. 2022. PMID: 35857659 Clinical Trial.
Optimizing treatment selection and sequencing decisions for first-line maintenance therapy of newly diagnosed advanced ovarian cancer.
Goh JCH, Gourley C, Tan DSP, Nogueira-Rodrigues A, Elghazaly H, Edy Pierre M, Giornelli G, Kim BG, Morales-Vasquez F, Tyulyandina A. Goh JCH, et al. Among authors: morales vasquez f. Gynecol Oncol Rep. 2022 Jun 17;42:101028. doi: 10.1016/j.gore.2022.101028. eCollection 2022 Aug. Gynecol Oncol Rep. 2022. PMID: 35813356 Free PMC article. Review.
Epidemiological Profile, Gastrointestinal Toxicity, and Treatment of Pelvic Cancers in Patients Managed with Radiotherapy to the Abdominal Pelvic Area.
Cetina-Pérez L, Serrano-Olvera A, Flores-Cisneros L, Jiménez-Lima R, Alvarado-Silva C, Díaz-Romero MDC, Morales-Vásquez F, Muñoz-González DE, Mota-García A, Chávez-Fierro OA, Jaramillo-Manzur SC, de la Garza-Salazar J, Castro-Eguiluz D, Meneses-García A. Cetina-Pérez L, et al. Among authors: morales vasquez f. Rev Invest Clin. 2018;70(3):112-116. doi: 10.24875/RIC.18002528. Rev Invest Clin. 2018. PMID: 29943771 Free article. Review.
Clinical Benefits of Olaparib in Mexican Ovarian Cancer Patients With Founder Mutation BRCA1-Del ex9-12.
Gallardo-Rincón D, Montes-Servín E, Alamilla-García G, Montes-Servín E, Bahena-González A, Cetina-Pérez L, Morales Vásquez F, Cano-Blanco C, Coronel-Martínez J, González-Ibarra E, Espinosa-Romero R, María Alvarez-Gómez R, Pedroza-Torres A, Castro-Eguiluz D. Gallardo-Rincón D, et al. Among authors: morales vasquez f. Front Genet. 2022 Jun 6;13:863956. doi: 10.3389/fgene.2022.863956. eCollection 2022. Front Genet. 2022. PMID: 35734436 Free PMC article.
Primary gastric hemangioblastoma: report of a case.
Basave HN, Morales-Vasquez F, Monterrubio JC, Gomez AH, Molina JM, Esquivel GM, Lino-Silva LS. Basave HN, et al. Among authors: morales vasquez f. Rare Tumors. 2015 Mar 31;7(1):5679. doi: 10.4081/rt.2015.5679. eCollection 2015 Feb 11. Rare Tumors. 2015. PMID: 25918611 Free PMC article.
[The first Mexican consensus of endometrial cancer. Grupo de Investigación en Cáncer de Ovario y Tumores Ginecológicos de México].
Ruvalcaba-Limón E, Cantú-de-León D, León-Rodríguez E, Cortés-Esteban P, Serrano-Olvera A, Morales-Vásquez F, Sosa-Sánchez R, Poveda-Velasco A, Crismatt-Zapata A, Santillán-Gómez A, Aguilar-Jiménez C, Alanís-López P, Alfaro-Ramírez P, Alvarez-Avitia MA, Aranda-Flores CE, Arias-Ceballos JH, Arrieta-Rodríguez O, Barragán-Curiel E, Botello-Hernández D, Brom-Valladares R, Cabrera-Galeana PA, Cantón-Romero JC, Capdeville-García D, Cárdenas-Sánchez J, Castorena-Roji G, Cepeda-López FR, Cervantes-Sánchez G, Cetina-Pérez Lde C, Coronel-Martínez JA, Cortés-Cárdenas SA, Cruz-López JC, de la Garza-Salazar JG, Díaz-Romero C, Dueñas-González A, Valle-Solís AE, Escudero-de los Ríos P, Flores-Alvarez E, García-Matus R, Gerson-Cwilich R, González-Enciso A, González-de-León C, Guevara-Torres AG, Herbert-Núñez GS, Hernández-Hernández C, Hernández-Hernández DM, Isla-Ortiz D, Jesús-Sandoval R, Jiménez-Cervantes C, Kuri-Exsome R, López-Obispo JL, Maffuz-Aziz A, Martínez-Barrera LM, Medina-Castro JM, Montalvo-Esquivel G, Mora-Aguilar VH, Morales-Palomares MA, Morán-Mendoza A, Morgan-Villela G, Mota-García A, Muñoz-González DE, Murillo-Cruz DA, Novoa-Vargas A, Ochoa-Carrillo FJ, Oñate-Ocaña LF, Or… See abstract for full author list ➔ Ruvalcaba-Limón E, et al. Among authors: morales vasquez f. Rev Invest Clin. 2010 Nov-Dec;62(6):583, 585-605. Rev Invest Clin. 2010. PMID: 21416918 Spanish.
[Third National Ovarian Consensus. 2011. Grupo de Investigación en Cáncer de Ovario y Tumores Ginecológicos de México "GICOM"].
Gallardo-Rincón D, Cantú-de-León D, Alanís-López P, Alvarez-Avitia MA, Bañuelos-Flores J, Herbert-Núñez GS, Oñate-Ocaña LF, Pérez-Montiel MD, Rodríguez-Trejo A, Ruvalcaba-Limón E, Serrano-Olvera A, Ortega-Rojo A, Cortés-Esteban P, Erazo-Valle A, Gerson-Cwilich R, De-la-Garza-Salazar J, Green-Renner D, León-Rodríguez E, Morales-Vásquez F, Poveda-Velasco A, Aguilar-Ponce JL, Alva-López LF, Alvarado-Aguilar S, Alvarado-Cabrero I, Aquino-Mendoza CA, Aranda-Flores CE, Bandera-Delgado A, Barragán-Curiel E, Barrón-Rodríguez P, Brom-Valladares R, Cabrera-Galeana PA, Calderillo-Ruiz G, Camacho-Gutiérrez S, Capdeville-García D, Cárdenas-Sánchez J, Carlón-Zárate E, Carrillo-Garibaldi O, Castorena-Roji G, Cervantes-Sánchez G, Coronel-Martínez JA, Chanona-Vilchis JG, Díaz-Hernández V, Escudero-de-los Ríos P, Garibay-Cerdenares O, Gómez-García E, Herrera-Montalvo LA, Hinojosa-García LM, Isla-Ortiz D, Jiménez-López J, Lavín-Lozano AJ, Limón-Rodriguez JA, López-Basave HN, López-García SC, Maffuz-Aziz A, Martínez-Cedillo J, Martínez-López DM, Medina-Castro JM, Melo-Martínez C, Méndez-Herrera C, Montalvo-Esquivel G, Morales-Palomares MA, Morán-Mendoza A, Morgan-Villela G, Mota-García A, Muño… See abstract for full author list ➔ Gallardo-Rincón D, et al. Among authors: morales vasquez f. Rev Invest Clin. 2011 Nov-Dec;63(6):665-702. Rev Invest Clin. 2011. PMID: 23650680 Spanish.
Simultaneous expression of steroid sulfatase and androgen receptor reduced overall survival of patients with epithelial ovarian tumors.
Calvillo-Robledo A, Pedernera E, Morales-Vásquez F, Pérez-Montiel D, Gómora MJ, Almaraz MÁ, de Alba Graue PG, Rendón E, López-Basave HN, Quintanar-Stephano A, Méndez C. Calvillo-Robledo A, et al. Among authors: morales vasquez f. J Ovarian Res. 2021 Jul 29;14(1):98. doi: 10.1186/s13048-021-00840-x. J Ovarian Res. 2021. PMID: 34321053 Free PMC article.
Sexual steroid hormone receptors profiles of ovarian carcinoma in Mexican women.
Gómora MJ, Morales-Vásquez F, Pedernera E, Perez-Montiel D, López-Basave H, Villa AR, Hernández-Martínez A, Mena E, Mendez C. Gómora MJ, et al. Among authors: morales vasquez f. Endocr Connect. 2018 Sep 1;7(9):1006-1012. doi: 10.1530/EC-18-0158. Endocr Connect. 2018. PMID: 30012649 Free PMC article.
26 results